Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Clinical trial NCT00113347 · COMPLETED
Trial details
- NCT number
- NCT00113347
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2011-04-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.